📢 Thrilled to announce our latest research in @CellCellPress! We've created a global ‘superbug map’ for a critically antibiotic-resistant bacterium to inform #phagetherapy 🧵1/11 https://t.co/TVAzlSOxIx
My lab is looking for a🚨Research Assistant🚨.
Using synthetic genomics and protein engineering, we'll design microbes and proteins with New-to-Nature functions.
Job ad and details below. RTs are much appreciated!
New paper out in @NatureComms
We usually think of bacteriophages as viruses that interact exclusively with bacteria.
Our work suggests the story is more complex: https://t.co/1bEIDdFVcq
We’d love your thoughts!
@ApjokGabor#phages#microbiome#virome
Can bacteria’s natural enemies help break the cycle of recurrent UTIs?
@KintsesLab at @BiologicalRese1 joins REPhRAME, a €15M @HorizonEU clinical project coordinated by @UK_Frankfurt, testing phage therapy + gut microbiome restoration
New preprint: We mapped global receptor-binding protein compatibility across 1,270 Klebsiella and Acinetobacter phages — identifying conserved adapter domains that define host-range modules for programmable phage engineering
https://t.co/k6hkdDumkE
#phage#AMR#syntheticbiology
Turns out phages go beyond binding to mucus.
Many latch onto epithelial cells, get internalized, and traffic to the ER using Ig-like adhesins encoded by some of the most abundant gut phages.
Our new preprint is out: https://t.co/kpAjmPR2rH
#phages#preprint#microbiome
Excited for #ESCMIDGlobal kicking off this week—hope to see you in Vienna! 🇦🇹
Our lab is presenting two posters:
Sunday: P2395 | Session 05a
Monday: P1835 | Session 03g
Come say hi and chat phages & resistance!
Excited to share a new collaboration with the @Csaba_Pal_Lab, out now in @NatureMicrobiol!
The study highlights how ESKAPE pathogens adapt to emerging antibiotics:
🚨 Excited to share that our new study, “ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro” is just published in @NatureMicrobiol. For details, see the 🧵below and read the paper here: https://t.co/2ekk5ACcDr
After a year of hard work and breakthrough success, we came together for a festive Christmas party. 🧑🔬🍕@ApjokGabor even brewed our own beer—fittingly named Scientists' Bloody Sweat! 🍻 Cheers to innovation and teamwork!Happy holidays from all of us at the Kintses Lab! 🎅#LabLife
A team of Hungarian scientists (@KintsesLab & @balazs_papp_lab) created a global ‘superbug map’ for A. baumannii strains, paving the way for scalable phage therapy to combat AMR infections.
Check out the feature blog post in this week's Capsid & Tail to learn more!
📢 Historic day for Portugal and phage therapy! 🇵🇹 A framework was approved, allowing magistral preparation of personalized phage products. 🙌 Grateful to Jean-Paul Pirnay, my group @AzeredoLab Portuguese patients, and doctors who signed a petition inspired by the Belgium model.
The guest speaker of today's Institute of Genetics seminar was Bálint Kintses, head of the Laboratory of Translational Microbiology at the BRC Institute of Biochemistry. His work on bacteriophage cocktail therapy was published in Cell.
First "Superbug Map" May Advance Phage Therapy for Acinetobacter baumannii
Scientists have created a global "superbug map," paving the way for scalable #phagetherapy to combat antibiotic-resistant infections in hospitals.
https://t.co/k3DgE8kTE6
Magistral phage preparation according to the Belgium model of phage therapy is being discussed by the Portuguese government. @azeredo_joana and @DPP_Pires were at the parliament to present the concept as a result of a petition initiated by two patients who received phage therapy.
🌐 Bridging fields: #Pathogengenomicsurveillance has revolutionized epidemiology and vaccine development, but its potential in phage therapy remains untapped. Our study highlights the need to bring these fields together. 9/10
🙏 Gratitude: This journey has been incredible. The work was a collaboration between @KintsesLab, @balazs_papp_lab, @Csaba_Pal_Lab from @BiochemBrc, @BiologicalRese1, the National Public Health Centre (Hungary). Huge thanks to our incredible team and international partners! 10/11